NCT07114289 Spontaneous Breathing Trials Using Pressure Support or T-Piece in Overweight and Obese Patients
| NCT ID | NCT07114289 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Medical University Hospital |
| Condition | Mechanical Ventilation |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-09-29 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-09-29 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to find out which method of spontaneous breathing trial (SBT) better helps overweight and obese ICU patients prepare for extubation, which is the removal of the breathing tube. The two methods being compared are pressure support ventilation (PSV) and the T-piece. Participants are adults with a body mass index (BMI) of 25 or higher who have been on a breathing machine (invasive mechanical ventilation) for more than 24 hours. Before removing the breathing tube, participants will be randomly assigned to receive either a PSV or a T-piece trial for 1 hour. After that, doctors will decide if they are ready for extubation. The main question this study wants to answer is: Which method leads to a higher rate of successful extubation-defined as not needing to be reintubated within 72 hours?
Eligibility Criteria
Inclusion Criteria: 1\. Patients had undergone intubation and mechanical ventilation for more than 24 hours prior to the first spontaneous breathing trial. 2\. Adult patients aged ≥ 18 years. 3. BMI ≥ 25 kg/m². 4. Meeting all the Inter national Consensus Conference on weaning criteria: 1. Stable vital signs: heart rate \< 140 beats/min, systolic blood pressure: 90-160 mmHg, and no use of vasopressors or use of minimal doses (\<0.2 µg/kg per min). 2. Respiratory rate ≤ 35 breaths/min. 3. Adequate oxygenation, defined as either SpO2 \> 90% with FiO2 ≤ 0.4, or PaO2/FiO2 \> 150 mmHg with positive end-expiratory pressure (PEEP) ≤ 8 cmH2O. 4. Adequate cough strength (MIP \< -20 cmH2O). 5. An awake state, defined as a score of Richmond Agitation-Sedation Scale between +1 and -2, or Glasgow Coma Scale \> 8. 6. No continuous sedation. 5. Informed consent provided by the patient or their relatives. Exclusion Criteria: 1. Patients with tracheostomy. 2. Patients who had been admitted for traumatic brain injury. 3. Patients who had preexisting peripheral neuromuscular disease (underlying myopathy or myasthenia gravis). 4. Patients who had a do-not-reintubate order at the time of the initial spontaneous breathing trial were excluded 5. Patients who have already undergone a first spontaneous breathing trial. 6. Patients who had undergone extubation without an SBT 7. Protected populations: pregnant or breastfeeding women, individuals under guardianship, or those under legal protection. 8. Patients who refused to participate during the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07114289 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mechanical Ventilation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07114289 currently recruiting?
Yes, NCT07114289 is actively recruiting participants. Contact the research team at lynnho0326@gmail.com for enrollment information.
Where is the NCT07114289 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07114289 clinical trial?
NCT07114289 is sponsored by Taipei Medical University Hospital. The trial plans to enroll 100 participants.